Pulse-treatment of U-937 human promonocytic cells with cadmium chloride followed by recovery caused caspase-9/caspase-3-dependent, caspase-8-independent apoptosis. However, pre-incubation with the glutathione (GSH)-suppressing agent DL-buthionine-(S,R)-sulfoximine (cadmium/BSO), or co-treatment with H 2 O 2 (cadmium/H 2 O 2 ), switched the mode of death to caspase-independent necrosis. The switch from apoptosis to necrosis did not involve gross alterations in Apaf-1 and pro-caspase-9 expression, nor inhibition of cytochrome c release from mitochondria. However, cadmium/H 2 O 2 -induced necrosis involved ATP depletion and was prevented by 3-aminobenzamide, while cadmium/BSO-induced necrosis was ATP independent. Pre-incubation with BSO increased the intracellular cadmium accumulation, while co-treatment with H 2 O 2 did not. Both treatments caused intracellular peroxide overaccumulation and disruption of mitochondrial transmembrane potential ( m). However, while post-treatment with N-acetyl-L-cysteine or butylated hydroxyanisole reduced the cadmium/BSO-mediated necrosis and m disruption, it did not reduce the effects of cadmium/H 2 O 2 . Bcl-2 over-expression, which reduced peroxide accumulation without affecting the intracellular GSH content, attenuated necrosis generation by cadmium/H 2 O 2 but not by cadmium/BSO. By contrast, AIF suppression, which reduced peroxide accumulation and increased the GSH content, attenuated the toxicity of both treatments. These results unravel the existence of two different oxidation-mediated necrotic pathways in cadmium-treated cells, one of them resulting from ATP-dependent apoptosis blockade, and the other involving the concurrence of multiple regulatory factors.
Introduction
Cadmium is an occupational and widespread environmental contaminant with mutagenic, teratogenic and carcinoCorrespondence to: P. Aller, Centro de Investigaciones Biológicas (CSIC), Ramiro de Maeztu 9, 28040,Madrid,Spain. Tel.: 34-9183-73112 (Ext. 4247); Fax: 34-915360432; e-mail: aller@cib.csic.es genic properties. 1 Because of its long lifetime, prolonged exposures may allow this heavy metal to accumulate and cause severe lesions in virtually all organs and tissues. At moderate to low concentrations, cadmium preferentially causes death by apoptosis both under in vivo and in vitro conditions, although the exact mechanism of executioni.e., the "intrinsic" (caspase-9-dependent) pathway, the "extrinsic" (caspase-8-dependent) pathway, or even a caspase-independent process-remains controversial. [2] [3] [4] Nevertheless, cadmium treatment also induces necrotic cell death, a response which may depend on the used metal concentration or which may be facilitated by the endogenous physiological characteristics of the cell. 5, 6 The importance of the distinction between apoptosis and necrosis goes beyond theoretical considerations. Thus, while apoptotic cells (or the resulting apoptotic bodies) are readily engulfed by vicinal phagocytes, necrosis ends in cell membrane disintegration and dissemination of intracellular material, with severe damage for the surrounding tissue.
The glutathione (GSH)-based redox system is one of best known determinants of the toxicity of heavy metals and metal-containing compounds. In this regard, we earlier reported that the administration of the GSH suppressing agent DL-buthionine-(S,R)-sulfoximine (BSO), a specific inhibitor of γ -glutamylcysteine synthetase, 7 potentiated the cadmium toxicity in human promonocytic cells, causing under extreme conditions a change in the mode of death, from apoptosis to necrosis. 8 Of note, BSO also causes overaccumulation of reactive oxygen species (ROS), 9 and ROS over-accumulation may be deleterious per se or enhance the lethality of other agents. 10, 11 Nevertheless, it is difficult to unequivocally identify a single factor as responsible for the increase in toxicity under GSH-depleting conditions, due to the multiplicity of protective functions of the glutathionebased machinery. Thus, in addition to its role as a ROS scavenger (either by direct ROS-GSH interaction or by intermediation of glutathione peroxidases), GSH is involved in the inactivation/detoxification of xenobiotics (by intermediation of glutathione transferases), and protects protein thiols from oxidative damage by forming transient mixed disulfides. 12 To shed some light on this problem, in the present work we comparatively analyzed the modulation of cadmium toxicity under two different forms of oxidative stress, namely pre-incubation with BSO and addition of exogenous H 2 O 2 . The obtained results demonstrate that both treatments cause a necrotic-like form of death with similar phenotypic characteristics, but with different regulation. Thus, while necrosis induction by cadmium plus H 2 O 2 may be considered as the consequence of aborted apoptosis, due to energy deprivation, necrosis induction by cadmium plus BSO appears as a primary response resulting from the concurrence of multiple factors.
Materials and methods

Reagents and antibodies
All components for cell culture were obtained from Invitrogen, Inc. (Carlsbad, CA, USA). Cadmium chloride was obtained from Merck (Darmstadt, Germany). 4,6-diamidino-2-phenylindole (DAPI) was obtained from Serva (Heidelberg, Germany). Digitonin, caspase-3 substrate I (Ac-DEVD-pNA), and caspase-9 substrate II (LEHD-pNA), were obtained from Calbiochem (Darmstadt, Germany). The
, and ZLeu-Glu-His-Asp(OMe)-CH 2 F (Z-LEHD-FMK) were obtained from Enzyme System Products (Aurora, OH, USA). Monochlorobimane, dichlorodihydrofluorescein diacetate (H 2 DCFDA), and rhodamine 123 (R123), were obtained from Molecular Probes (Eugene, OR, USA). Mouse anti-pigeon cytochrome c monoclonal antibody (mAb) (clone 7H8.2C12), rabbit anti-human apoptotic proteaseactivating factor 1 (Apaf-1) polyclonal antibody (pAb), mouse anti-human caspase-9 mAb, and mouse anti-Bax mAb clone 6A7, were from BD PharMingen (San Diego, CA, USA); mouse anti-human Bcl-2 (100) mAb and rabbit anti-human Bax (N-20) pAb were from Santa Cruz Biothechnology (Santa Cruz, CA, USA); rabbit anti-human p44/42 MAPK pAb was from Cell Signaling Technology (Beverly, MA); mouse anti-human 70-kDa heat-shock protein (HSP70) mAb (clone C92F3A-5, which specifically recognizes the stress-inducible form of HSP-70) was from StressGen Biotechnologies (Victoria, Canada); peroxidaseconjugated rabbit anti-mouse immunoglobulin G and peroxidase conjugated goat anti-rabbit immunoglobulin G were from DAKO Diagnósticos (Barcelona, Spain); and fluorescein isothiocyanate-conjugated goat anti-mouse immunoglobulin G were from Serotec GmbH (Düsseldorf, Germany). All other reagents were obtained from Sigma Química (Madrid, Spain).
Cells and treatments
U-937 13 and Bcl-2-transfected U-937 cells 14 (kindly provided by Dr. Jackeline Bréard, Institut Nationale de la Santé et Recherche Médicale (INSERM) 461, Chatenay Malabry, France) were routinely grown in RPMI 1640 supplemented with 10% (v/v) heat-inactivated fetal bovine serum, and 0.2% sodium bicarbonate and antibiotics in a humidified 5% CO 2 atmosphere at 37
• C. Stock solutions of DAPI (10 µg/ml), propidium iodide (PI, 1 mg/ml) and R123 (1 mg/ml) were prepared in phosphate-buffered saline (PBS) and stored at 4
• C. Stock solutions of monochlorobimane (200 mM), N-acetyl-L-cysteine (NAC, 3 M), and Z-VAD-FMK (20 mM) were prepared in dimethyl sulfoxide and stored at −20
• C. Stock solutions of butylated hydroxyanisole (BHA, 0.5 mM) and H 2 DCFDA (5 mM) were prepared in ethanol, and kept at −20
• C. Stock solutions of 3-aminobenzamide (3-ABA, 200 mM) and cadmium chloride (CdCl 2 200 mM) were prepared in distilled water and stored at −20
• C. BSO (50 mM) was freshly prepared in distilled water just before use. Typically, the cells were seeded at 2×10 5 cells/ml 16 h before treatments. For cadmium experiments, the cells were pulse-treated for 2 h with 200 µM cadmium chloride, then washed with pre-warmed (37
• C) RPMI medium and let to recover under standard culture conditions. As controls, cells were subjected to the same manipulations as treated cells, in the absence of cadmium. For GSH depletion, the cells were incubated for 24 h with 1 mM BSO, which was also present during the cadmium treatment. BSO did not affect cell proliferation or viability, at least for 36 h.
Nucleofection of small interfering RNAs (siRNAs)
U-937 cells were nucleofected with a small interfering RNA (siRNA) doubled-stranded oligonucleotide designed to interfere with the expression of human apoptosis-inducing factor (AIF) (sense strain: 5 -CCGGUCCCAGGCAACUUG-3 , Proligo, Boulder, CO). As a control, an irrelevant siRNA oligonucleotide (sense strain: 5 -GUAAGACACGACUUAUCGC-3 ) was used. The assay was carried out using the optimized protocol for U-937 cells developed by the manufacturer (Amaxa Biosystems, Cologne, Germany). Namely, 2×10 6 cells were centrifuged and resuspended in 100 µl of Nucleofector solution (Cell line Nucleofector kit V, Amaxa Biosystems), after which the siRNAs were added, to a final concentration of 9 nM. The samples were nucleofected using the program V-01 (Amaxa Nucleofector v.2.1., Amaxa Biosystems), and then transferred to 3 ml of fresh culture medium. AIF expression was analyzed at the desired incubation times by means of immunoblot.
Determination of apoptosis and necrosis
Distinctive characteristics of apoptotic cells were a marked reduction in cell volume, chromatin condensation and Regulation of Cadmium toxicity by oxidant agents fragmentation, and loss of DNA (sub-G 1 DNA content). Chromatin condensation was examined by DAPI staining and examination by fluorescence microscopy; and loss of DNA by cell permeabilization followed by PI staining and flow cytometry examination, as earlier described. 15 Distinctive characteristics of genuine necrosis are cell swelling (specially in the BSO plus cadmium treatment) and loss of plasma membrane integrity. The loss of membrane integrity was evidenced by the free penetration of trypan blue, as revealed by microscopy examination; or by the freepenetration of PI in non-permeabilized cells, as revealed by flow cytometry. 15 
Measurement of peroxide levels and mitochondrial transmembrane potential
The intracellular peroxide content and the alterations in mitochondrial transmembrane potential ( m) were determined by flow cytometry after loading the cells with the peroxide-sensitive probe H 2 DCFDA or the cationic agent R123, respectively, following the previously described procedures. 15 
Flow cytometry assays
The analysis of samples was carried out using an EPICS XL flow cytometer (Coulter, Hialeah, FL) equipped with an air-cooled argon laser tuned to 488 nm. The specific fluorescence signal corresponding to PI was collected with a 620 nm band pass filter, and the signals corresponding to H 2 DCFDA, and R123 with a 525 nm band pass filter. To determine the level of active Bax, cells were fixed with 3.5% (vol/vol) formaldehyde and permeabilized with 0.1% (wt/vol) saponin in PBS for 5 min on ice. After incubation for 30 min at 4
• C with anti-Bax antibody clone 6A7, and for 30 min at 4
• C with FITC-conjugated anti-IgG antibody, the fluorescence was estimated by flow cytometry. The 6A7 clone recognizes a NH 2 -terminal region of Bax that is occluded under normal conditions, but that is exposed as a consequence of changes in conformation associated to Bax translocation to mitochondria in stressed cells. 16 
Caspase activity assays
In vitro assays of caspase-3 and caspase-9 activities were carried out by spectrometry using cell extracts and the synthetic substrates Ac-DEVD-pNA and LEHD-pNA, as earlier described. 17 
Measurement of intracellular GSH and ATP content
The total intracellular GSH content was determined by fluorimetry after loading the cells with the GSH-sensitive probe monochlorobimane. The intracellular ATP content was determined by means of the luciferin/luciferase assay procedure. These techniques were described in detail elsewhere. 15 
Protein extraction and immunoblot assays
To obtain total cellular protein extracts, cells were collected by centrifugation, washed with PBS, and lysed by 5 min heating at 100
• C followed by sonication in Laemmli's buffer. To obtain cytosolic protein extracts (aimed at determining cytocrome c release), cells were collected by centrifugation, resuspended in 100 µl of ice-cold PBS containing 80 mM KCl, 250 mM sucrose, and 200 µg/ml digitonin, and kept on ice for 5 min. After centrifugation the supernatants (representing the cytosolic extracts) were collected. The detection of specific proteins was carried out by immunoblot, as previously described. 17 
Assessment of intracellular cadmium content
After extensive washing with cold PBS, the cells were lysed as indicated above, and the amount of cadmium in the lysates determined by means of flow injection-inductively coupled plasma mass spectrometry. The procedure was as previously described for platinum and arsenic, 18 except that 111 Cd was used as an internal standard.
Statistical analysis
As a routine, the significance of differences between experimental conditions was examined using the Student's t test, and when positive represented by asterisks ( * , P < 0.01; * * , P < 0.005).
Results
Death induction and caspase activities
In precedent works aimed at analyzing cadmium effects, we adopted an experimental design consisting in a 2 h pulsetreatment with CdCl 2 followed by recovery in metal-free medium. This procedure allows a better apoptotic response without contamination of necrosis, in comparison to continuous cadmium treatment. 8 Hence, this design was also adopted in the present work. Pulse-treatment of U-937 cells with 200 µM CdCl 2 rapidly elicited a typical apoptotic response, as manifested by cell shrinkage (not shown), chromatin fragmentation ( Figure 1A ), and sub-G1 DNA content ( Figure 1C ). However, the mode of death switched to necrosis when cadmium treatment was preceded by incubation with BSO (24 h at 1 mM), as manifested by rapid increase in cell volume (not shown) and free penetration of trypan blue Figure 1 . Generation of apoptosis and necrosis by cadmium chloride, either alone or in combination with BSO and H 2 O 2 . As a general experimental scheme, U-937 cells were pulse-treated for 2 h with 200 µM CdCl 2 (Cd). In some cases, the CdCl 2 treatment was preceded by a 24 h pre-incubation with 1 mM BSO, which was also maintained during CdCl 2 treatment (Cd/BSO). In other cases, the CdCl 2 treatment was carried out in the presence of H 2 O 2 (Cd/H 2 O 2 ). In all cases, the pulse-treatment period was followed by recovery in drug-(CdCl 2 or PI ( Figure 1A and C), with concomitant disappearance of apoptotic markers.
Since one of the expected consequences of GSH depletion is the increase in intracellular peroxide accumulation, 9, 15 we asked whether the effects elicited by BSO could be mimicked by exogenous H 2 O 2 administration. As indicated in Figure 1B , co-treatment with CdCl 2 plus increasing concentrations of H 2 O 2 (from 0.1 to 1 mM) caused a dosedependent diminution in the frequency of apoptotic cells with a concomitant increase in necrosis, with maximum efficacy at 1 mM H 2 O 2 . Nevertheless, under these conditions the execution of necrosis was delayed in relation to the timing of apoptosis execution in cadmium-treated cells, and to necrosis execution in cadmium/BSO-treated cells ( Figure 1B and C). This delay could not be prevented by increasing the H 2 O 2 concentration (data not shown).
To characterize the pathway of apoptosis execution, experiments were carried out using the caspase inhibitors Z-VDVAD-FMK (specific for caspase-2), Z-DEVD-FMK (specific for caspase-3), Z-IETD-FMK (specific for capase-8), Z-LEDH-FMK (specific for caspase-9), and the pan-caspase inhibitor Z-VAD-FMK. As shown in Figure 2A , apoptosis was greatly reduced by Z-VAD, Z-LEDH and Z-DEVD, but not by Z-VDVAD or Z-IETD. This indicates that cadmium Figure 2 . Caspase activities and effect of caspase inhibitors. (A) Frequency of apoptotic and necrotic cells at 6 h of recovery, in the absence (−) or the presence of Z-VDVAD-FMK (caspase-2 inhibitor), Z-DEVD-FMK (caspase-3 inhibitor), Z-IETD-FMK (caspase-8 inhibitor), Z-LEHD-FMK (caspase-9 inhibitor), and Z-VAD-FMK (non-specific caspase inhibitor).The inhibitors (used at 50 µM) were added 30 min before CdCl 2 , and maintained during the treatment and recovery periods. Asterisks indicate significant differences in the frequency of apoptosis, in relation to treatment with Cd alone (−). (B) Total cellular extracts (10 µg of protein per sample) were used to determine caspase-9 and -3 activities at 3 and 6 h of recovery, using as substrates LEHD-pNA and Ac-DEVD-pNA, respectively. Asterisks indicate significant differences in relation to Cont. The results (mean ± S.D. of at least three determinations) were normalized in relation to untreated (Cont) cells, which received the arbitrary value of one. All other conditions were as in Figure 1. induces apoptosis along the "intrinsic" (mitochondrial) pathway, without apparent participation of the "extrinsic" pathway. The involvement of the caspase-9/ caspase-3 pathway was corroborated by directly measuring these caspase activities ( Figure 2B ). As expected, necrosis generation by cadmium/BSO and cadmium/H 2 O 2 was not affected by Z-VAD (Figure 2A) , and the treatments did not elicit caspase-9 or caspase-3 activation ( Figure 2B ), corroborating that it represents bona fide caspase-independent necrosis.
Regulation of Cadmium toxicity by oxidant agents
Mitochondria-related events
The execution of the intrinsic pathway of apoptosis requires the release of cytochrome c from mitochondria to the cytosol, and its assembly with Apaf-1 and pro-caspase-9 to form the apoptosome. [2] [3] [4] Hence, experiments were carried out to examine the expression, integrity and/or location of these proteins. The results are indicated in Figure 3A . Immunoblot assays using cytosolic extracts revealed the presence of cytochrome c in the cytosol of cells treated with cadmium alone, cadmium/BSO, and cadmium/H 2 O 2 -a result corroborated by flow cytometry and confocal microscopy determinations (result not shown); and immunoblot assays using total cellular extracts revealed the normal presence of Apaf-1 and pro-caspase-9 in cells subjected to all treatments. The only difference consisted in the decrease in pro-caspase-9 level at 3 h of cadmium treatment, which probably reflects apoptosis-associated enzyme cleavage/activation, and as such was not provoked by the necrosis-inducing treatments. Hence, the switch from apoptosis to necrosis may not be attributed to gross alterations in the main apoptosome components.
In addition, we examined the expression and/or processing of heat-shock protein 70 (HSP70) and some Bcl-2 protein family members, which are known to modulate cytochrome c release or other steps of the intrinsic pathway. 17, 19 It was found that cadmium alone induced the expression of the protective protein HSP70, while cadmium/BSO and cadmium/H 2 O 2 did not ( Figure 3B ). The total expression of Bcl-2 (anti-apoptotic) or Bax (pro-apoptotic) proteins remained unaffected ( Figure 3C ). However, both cadmium and cadmium/BSO elicited Bax activation, as demonstrated using an antibody which specifically recognized the active form of this protein ( Figure 3D ).
Intracellular ATP levels
The activation of the apoptosome requires dATP/ATP as an essential co-factor. 19 Moreover, ATP synthesis may be blocked as a consequence of H 2 O 2 -provoked oxidative stress, 10, 20 and the intracellular ATP level was reported to represent a critical factor for the selection between apoptosis and necrosis in many cell systems 21, 22 For these reasons, we found of interest to measure ATP levels under our experimental conditions. The results in Figure 4A indicate that cadmium/H 2 O 2 caused a great decrease in intracellular ATP, while cadmium alone and cadmium/BSO did not. The cause-effect relationship between ATP reduction and necrosis was demonstrated using 3-ABA, an agent which was reported to prevent oxidant-mediated ATP depletion and necrosis induction in other cell types.
23,24 3-ABA prevented the ATP decrease ( Figure 4A ) and attenuated the toxicity ( Figure 4B (B) Frequency of apoptotic and necrotic cells (mean ± S.D. of four determinations), in the absence (−) or presence (+) of 3-ABA. Except when indicated, the determinations were carried out at 6 h of recovery. 3-ABA was added 30 min before CdCl 2 , and maintained during the treatment and recovery periods. Asterisks in the Cd/H 2 O 2 determination indicate significant differences in apoptosis in ABAtreated (+) vs. ABA-untreated (−) cells. All other conditions were as in Figure 1 .
Intracellular ROS and GSH levels, cadmium accumulation, and effects of antioxidants
One of the functions of the GSH-dependent machinery is the detoxification of xenobiotics. 12 Hence, we asked whether the BSO-provoked GSH depletion could lead to changes in intracellular cadmium accumulation. As indicated in Figure 5A , incubation with BSO alone caused a great decrease in intracellular GSH, which was even higher in cadmium/BSO-treated cells. Under these conditions, preincubation with BSO elicited an increase in intracellular cadmium accumulation ( Figure 5B ). On the other hand, Figure 5 . Changes in intracellular GSH content and intracellular cadmium accumulation. (A) Relative GSH content after 24 h of incubation with BSO alone, and at 2 h of treatment with CdCl 2 alone, CdCl 2 plus BSO, and CdCl 2 plus H 2 O 2 . The results (mean ± S.D. of at least three determinations) are expressed in relation to the controls (approximate GSH content: 9.5 nmol/10 6 cells), which received the arbitrary value of one. Asterisks indicate significant differences in relation to Cont. (B) Intracellular cadmium accumulation in cells subjected to the same treatments as above. The results (mean ± S.D. of three determinations) are expressed in relation to cells treated with CdCl 2 alone (total cadmium content: 64.52 ± 7.88 ng cadmium/10 6 cells), which received the arbitrary value of one. Asterisks indicate significant differences in relation to Cd. All other conditions were as in Figure 1. although cadmium/H 2 O 2 slightly decreased GSH content ( Figure 5A ), co-treatment with H 2 O 2 did not augment, but instead reduced the intracellular cadmium accumulation ( Figure 5B ).
Another prominent function of the GSH-dependent machinery is the scavenging of intracellular peroxides. 12 For this reason, determinations using the peroxide-sensitive fluorescent probe H 2 DCFDA were carried out, to measure possible fluctuations in intracellular ROS accumulation. As indicated in Figure 6A , treatment with cadmium/H 2 O 2 initially caused a considerable increase in fluorescence (30 min) which disappeared thereafter (2 h). By contrast, cadmium/BSO caused a moderate increase at 30 min, but the increase was maintained and even augmented at the later time.
To examine the importance of peroxide accumulation for necrosis induction, experiments were then carried out using the antioxidant agents NAC and BHA. In these experiments the antioxidants were only added at the time of recoveryi.e., after cadmium removal. This was aimed at preventing possible direct interactions of cadmium with reactive groups in the antioxidant molecules (e.g., thiol groups in NAC), 25 and also to avoid the influence of antioxidant-mediated inhibition of heat-shock protein expression on cell death, as we earlier demonstrated. 17 The results in Figure 6B show that post-treatment with the antioxidants did not significantly alter the frequency of apoptosis in cells treated with cadmium alone, or the frequency of necrosis in cells treated with cadmium/H 2 O 2 .This later result seems to be consistent with the rapid spontaneous removal of intracellular peroxides in cells subjected to this treatment ( Figure 6A ). By contrast, BHA and NAC reduced the frequency of necrotic cells in cadmium/BSO-treated cultures, suggesting that the sustained intracellular oxidation is an important event for necrosis induction in this treatment. Of note, the attenuation of necrosis achieved by BHA and NAC was independent of GSH itself, since it was not accompanied by a significant restoration of the intracellular GSH levels ( Figure 6C) .
It has been indicated that cadmium directly targets the permeability transition pore of mitochondria, causing the dissipation of mitochondrial transmembrane potential ( m). 26 To assess the importance of m alterations for the apoptosis-necrosis switch, determinations using the cationic dye R123 were carried out. The results are represented in Figure 6D . It was found that cadmium treatment caused a slight fall in m at 3 h of recovery, which was greatly potentiated by BSO 
Effects of Bcl-2 over-expression
It has been stated that Bcl-2 promotes antioxidant functions in the cell, a property which may explain in part the well known anti-apoptotic action of this protein. 27, 28 In addition Bcl-2 over-expression was reported to inhibit necrosis in some systems. [29] [30] [31] For these reasons, we found of interest to analyze the effects of cadmium/BSO and cadmium/H 2 O 2 in Bcl-2-transfected U-937 cells (Bcl-2 cells). Preliminary determinations indicated that the used Bcl-2 cells displayed an approximately eight-fold increase in Bcl-2 level, similar Bax level, and low capacity to undergo apoptosis upon cadmium treatment, in relation to non-transfected, normal cells (results not shown). Concerning intracellular oxidation, we observed that the basal peroxide content was lower in Bcl-2 cells than in normal cells ( Figure 7A) ; and what is more, the initial increase in peroxide accumulation (30 min) elicited by both cadmium/H 2 O 2 and cadmium/BSO was more rapidly removed (1 h) in Bcl-2 cells ( Figure 7B ). In agreement with this, the frequency of necrosis caused by cadmium/H 2 O 2 was much lower in Bcl-2 cells than in normal cells ( Figure   7D ). By contrast, the frequency of necrosis caused by cadmium/BSO was not reduced in Bcl-2 cells (Figure 7D ), indicating an uncoupling between ROS accumulation and death induction with this treatment. On the other hand, there was a parallelism between necrosis induction and intracellular GSH, since both the basal GSH content and the decrease caused by BSO alone and cadmium/BSO were approximately the same in Bcl-2 and normal cells ( Figure  7C ). Taken together, these results corroborate the different regulation of cadmium/H 2 O 2 -and cadmium/BSOprovoked necrosis, and indicate that the alteration in cadmium toxicity derived from GSH depletion may not be simply explained by changes in ROS accumulation.
Effects of AIF downregulation
AIF was originally characterized as a mitochondrial protein which, after apoptosis induction, translocates to the nucleus where it participates in apoptotic chromatinolysis. 32 More recently, AIF was demonstrated to possess NADH activity, participating in the regulation of the redox state of the cell. 33, 34 In particular, alterations in AIF expression have been observed to affect ROS and/or GSH accumulation in different cell systems. [34] [35] [36] For this reason, we found of interest to investigate the possible influence of AIF suppression on cadmium/BSO-and cadmium/H 2 O 2 -provoked intracellular oxidation and toxicity. With this aim, cells were nucleofected with an AIF-directed siRNA (AIF-siRNA), and the results compared with those obtained using nonnucleofected cells or cells nucleofected with an irrelevant siRNA. AIF-siRNA effectively reduced AIF expression at 48 and 72 h post-nucleofection, as revealed by immunoblot assays ( Figure 8A) . As in the case of Bcl-2 over-expression, AIF suppression resulted in a decrease in peroxide accumulation, observed both in untreated cells ( Figure 8B ) and in cadmium/BSO-and cadmium/H 2 O 2 -treated cells (Figure 8C) . However, by contrast to Bcl-2 over-expression, AIF suppression resulted in a marked increase in GSH content ( Figure 8D ). Under these conditions, AIF-siRNA reduced the toxicity not only in cadmium/H 2 O 2 -treated cultures, but also in cadmium/BSO-treated cultures. Of note, the reduction in toxicity was here manifested as a switch back from necrosis to caspase-dependent apoptosis, as corroborated using the pan-caspase inhibitor Z-VAD-FMK ( Figure 8E ). On the other hand, AIF suppression totally abrogated cell death in Bcl-2-transfected U-937 cells (result not shown), which is consistent with the inability of these cells to execute apoptosis. Altogether, these results demonstrate that AIF is a central mediator in cadmium/BSO-and cadmium/H 2 O 2 -provoked necrosis.
Discussion
The results in this work corroborate earlier observations indicating that that pulse-treatment with cadmium chloride P. Sancho et al. followed by recovery causes death by apoptosis in U-937 human promonocytic cells. 8 Apoptosis occurred as a typical caspase-dependent process exclusively executed along the intrinsic (caspase-9-dependent) pathway, which contrasts with earlier observations using other cell types or different experimental designs. 2, 4 The present results also corroborate the dependence of cadmium toxicity on intracellular GSH content, manifested by a switch from apoptosis to necrosis following BSO pre-incubation, a phenomenon which could be reproduced by co-treatment with H 2 O 2 . Both cadmium/BSO-and cadmium/H 2 O 2 -induced necrosis developed as caspase-independent processes, which were nevertheless compatible with cytochrome c release and, at least in the case of cadmium/BSO, with Bax activation. On the other hand, necrosis execution was not compatible with the normal activation of the stress ("heat-shock") response, as indicated by the lack of HSP70 expression. We may speculate that the lack of HSP70, a protective protein, facilitates to some extent the increase in cadmium toxicity resulting in necrosis. Actually, our preliminary assays indicated that HSP70 over-expression delayed necrosis execution in cadmium/BSO-and cadmium/H 2 O 2 -treated cells (results not shown).
In spite of the phenotypical similarities, the regulation of necrosis by cadmium/BSO and cadmium/H 2 O 2 exhibited clear differences. Thus, (i) while necrosis was rapidly executed in cadmium/BSO-treated cells, the timing of necrosis execution by cadmium/H 2 O 2 was delayed in relation to apoptosis execution by cadmium alone. (ii) In addition, while cadmium/BSO-derived necrosis did not involve alterations in intracellular ATP levels, the switch from apoptosis to necrosis was strictly dependent on ATP depletion in cadmium/H 2 O 2 -treated cells. (iii) Finally, while necrosis induction by cadmium/BSO was independent of Bcl-2, necrosis induction by cadmium/H 2 O 2 behaved as a Bcl-2-regulated process, in the same manner as apoptosis. This later result is consistent with earlier reports indicating that Bcl-2 over-expression protects against necrosis induction by P. Sancho et al.
30 as well as necrosis derived from ATP depletion. 37, 38 According to these observations, the generation of necrosis by cadmium/H 2 O 2 may be contemplated as a consequence of aborted apoptosis, due to the inability to activate the caspase cascade. By contrast, necrosis induction by cadmium/BSO appears as a direct response, probably resulting from the rapid loss of cellular homeostasis. In this situation, mitochondrial events such as cytochrome c release and Bax activation, although still produced, might be irrelevant in terms of cell death regulation. The role of intracellular oxidation as a possible determinant of the apoptosis-necrosis switch was approached in two different ways, namely by analyzing ROS accumulation and the effect of antioxidants, and by altering the expression of proteins which are known to affect the redox state. Following the first approach we observed that cadmium/H 2 O 2 caused a transient accumulation of intracellular peroxides, while the accumulation was durable in the case of cadmium/BSO; and the late addition of BHA and NAC (i.e., their administration at the time of recovery after cadmium treatment) was able to attenuate necrosis execution and necrosis-associated m dissipation in cadmium/BSOtreated cells, but not in cadmium/H 2 O 2 -treated cells. The protective action of BHA and NAC must be attributed to their direct antioxidant action, since they did not restore the GSH levels, suggesting that the sustained intracellular oxidation (and the resulting mitochondrial damage) was an important determinant of toxicity in GSH-depleted cells. Following the second approach we observed that Bcl-2 exerted an antioxidant action, as manifested by the reduction in peroxide accumulation in Bcl-2-transfected cells, but in spite of it Bcl-2 over-expression did not attenuate necrosis induction by cadmium/BSO. By contrast AIF suppression, which not only attenuated peroxide accumulation but also increased the intracellular GSH content, reduced the toxicity of cadmium/BSO, as manifested by the partial reversion from necrosis to apoptosis. Taken together, these results suggest that the increase in toxicity in cadmium/BSO-treated cells is mediated by mechanisms other than ROS overaccumulation, and as such might appear as contradictory with those obtained using BHA and NAC. However, both blocks of information may be reconciled if we consider the following aspects. (i) It has been indicated that cadmium triggers apoptosis by directly affecting the mitochondria; 26 and it was also reported that BHA and NAC accumulate in the mitochondria, protecting its structure and function. 39, 40 Actually, in our experiments the attenuation of necrosis by BHA and NAC involved the protection of the mitochondrial function, as revealed by the partial restoration m. A possible explanation is that BHA and NAC may substitute GSH as local antioxidants, reducing the mitochondrial oxidative damage and preserving in this way the cell viability.
(ii) GSH may modulate cadmium toxicity by mechanisms other than ROS scavenging. In fact, we demonstrated that BSO-mediated GSH depletion resulted in an increase in intracellular cadmium accumulation, which should in turn lead to increased toxicity. Moreover, although not examined by us, it is conceivable that GSH depletion facilitates protein damage by rendering protein thiols unprotected and exposed to oxidation and cadmium binding. Among other proteins critical for cell death regulation, the alteration of some ion channel constituents could be particularly important to explain the rapid increase in volume and loss of cell homeostasis observed in cadmium/BSO-treated cells. 41 Proteomic assays will be designed to examine this hypothesis in cells treated with cadmium and some GSH-sensitive metal-containing drugs.
The results obtained in the AIF knock-down experiments deserve a separate comment. The observed reduction of peroxide accumulation following AIF suppression suggests that this protein exerts a pro-oxidant function in U-937 cells, which is congruent with its earlier characterization as a flavoprotein NADH oxidase; 33 and the observed increase in GSH content is in turn congruent with the reduction of peroxide accumulation. Nevertheless, Candé et al. 36 reported that AIF suppression did not increase, but instead favored GSH depletion in arsenate-treated HeLa and ES cells. On the other hand, Klein et al. 35 reported that AIF suppression increased the total glutathione content in mouse cerebellar granule cells, but in this case AIF behaved as a peroxide scavenger. Hence, the function of AIF as a redox modulator seems to be greatly dependent on the experimental conditions and used cell model. In addition, the recent work of Vahsen et al. 34 underlined the role of AIF in maintaining oxidative phosphorylation and ATP generation. Hence, more detailed study is required to fully understand the relationship between AIF expression, ATP generation, ROS production, and execution of apoptosis and necrosis.
Conclusion
In summary, the present results indicate that co-treatment with H 2 O 2 or pre-incubation with the glutathionedepleting agent BSO suppresses apoptosis and switches the mode of death to caspase-independent necrosis in human promonocytic cells. The generation of necrosis by cotreatment with H 2 O 2 may be considered as the consequence of aborted apoptosis, due to energy deprivation. On the other hand, the generation of necrosis by pre-incubation with BSO appears as a more complex process, which involves at least sustained ROS over-accumulation and increased cadmium intake.
BSO is a highly specific GSH synthesis inhibitor with low side toxic effects, both under in vivo and in vitro conditions. Because of this, co-treatment with BSO has been considered as a promising strategy to improve the cytotoxic action and hence the efficacy of GSH-sensitive antitumour drugs, and in fact pre-clinical assays have been developed with this aim. 7, 42 The present results strengthen the necessity of carefully controlling the conditions of BSO treatment, to avoid undesirable effects for the organism. Thus, instead Regulation of Cadmium toxicity by oxidant agents of increasing apoptosis, GSH depletion might facilitate the activation of a necrotic response, which must be avoided. Moreover, the down-regulation of the GSH-based machinery may reduce the normal defenses against harmful agents, including heavy metals and other environmental contaminants. A precise knowledge of the multiple factors by which GSH modulates cell death might help to minimize these problems.
